| AGENCY: HHS-ACF | RIN: 0970-AD34 | Status: Pending Review for rule 0970-AD34 | Request EO Meeting for rule 0970-AD34 |
| TITLE: Unaccompanied Alien Children Program Foundational Rule; Updates to Accord with the Hyde Amendment | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 01/23/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ACF | RIN: 0970-AD30 | Status: Pending Review for rule 0970-AD30 | Request EO Meeting for rule 0970-AD30 |
| TITLE: Modernize the Head Start Program by Reducing Requirements and Enhancing Alignment with State and Local Systems | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 05/22/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ACF | RIN: 0970-AD19 | Status: Pending Review for rule 0970-AD19 | Request EO Meeting for rule 0970-AD19 |
| TITLE: Designated Placements Requirements Under Titles IV-E and IV-B for LQBTQ+ Children; Rescission | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 05/29/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV83 | Status: Pending Review for rule 0938-AV83 | Request EO Meeting for rule 0938-AV83 |
| TITLE: CY 2027 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates (CMS-1850) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 04/13/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AV82 | Status: Pending Review for rule 0938-AV82 | Request EO Meeting for rule 0938-AV82 |
| TITLE: CY 2027 Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Medicare Part B (CMS-1848) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 04/14/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AV81 | Status: Pending Review for rule 0938-AV81 | Request EO Meeting for rule 0938-AV81 |
| TITLE: CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System and Quality Incentive Program (CMS-1846) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 04/22/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AW03 | Status: Pending Review for rule 0938-AW03 | Request EO Meeting for rule 0938-AW03 |
| TITLE: Exchange Pre-Enrollment Eligibility Verification (CMS-9873) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 04/22/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV80 | Status: Pending Review for rule 0938-AV80 | Request EO Meeting for rule 0938-AV80 |
| TITLE: CY 2027 Home Health Prospective Payment System Rate Update and Home Infusion Therapy Services Payment Update (CMS-1844) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 05/11/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AV70 | Status: Pending Review for rule 0938-AV70 | Request EO Meeting for rule 0938-AV70 |
| TITLE: Strengthening the Integrity of Medicaid and CHIP Managed Care, Financing, and Access to Care (CMS-2450) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 05/12/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV92 | Status: Pending Review for rule 0938-AV92 | Request EO Meeting for rule 0938-AV92 |
| TITLE: Short-Term, Limited-Duration Insurance (CMS-9881) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 05/30/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AW01 | Status: Pending Review for rule 0938-AW01 | Request EO Meeting for rule 0938-AW01 |
| TITLE: Request for Information; Clinical Laboratory Improvement Amendments (CLIA) of 1988 Regulations (CMS-3485) | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/01/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV74 | Status: Pending Review for rule 0938-AV74 | Request EO Meeting for rule 0938-AV74 |
| TITLE: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model (CMS-5546) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 06/15/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AV73 | Status: Pending Review for rule 0938-AV73 | Request EO Meeting for rule 0938-AV73 |
| TITLE: Prohibition on Federal Medicaid and Children's Health Insurance Program Funding for Specified Sex-Rejecting Procedures Furnished to Children and Youth (CMS-2451) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 06/16/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV75 | Status: Pending Review for rule 0938-AV75 | Request EO Meeting for rule 0938-AV75 |
| TITLE: FY 2027 Skilled Nursing Facility (SNFs) Prospective Payment System and Consolidated Billing and Updates to the Value-Based Purchasing and Quality Reporting Programs (CMS-1843) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 06/18/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AV93 | Status: Pending Review for rule 0938-AV93 | Request EO Meeting for rule 0938-AV93 |
| TITLE: Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes (CMS-2452) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 12/31/2025 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-FDA | RIN: 0910-AI94 | Status: Pending Review for rule 0910-AI94 | Request EO Meeting for rule 0910-AI94 |
| TITLE: Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 03/04/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-FDA | RIN: 0910-ZC82 | Status: Pending Review for rule 0910-ZC82 | Request EO Meeting for rule 0910-ZC82 |
| TITLE: Cannabidiol (CBD) Products Compliance and Enforcement Policy | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 03/13/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZC89 | Status: Pending Review for rule 0910-ZC89 | Request EO Meeting for rule 0910-ZC89 |
| TITLE: Serotonin-2A Agonists and Related Products: Considerations for Clinical Investigations; Guidance for Industry; Availability | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 04/17/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AI72 | Status: Pending Review for rule 0910-AI72 | Request EO Meeting for rule 0910-AI72 |
| TITLE: Use of Salt Substitutes to Reduce the Sodium Content in Standardized Foods | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 04/20/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AI98 | Status: Pending Review for rule 0910-AI98 | Request EO Meeting for rule 0910-AI98 |
| TITLE: Food Standards of Identity Modernization; Pasteurized Orange Juice | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 05/08/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD09 | Status: Pending Review for rule 0910-ZD09 | Request EO Meeting for rule 0910-ZD09 |
| TITLE: Action Levels for Cadmium in Processed Food Intended for Babies and Young Children; Draft Guidance for Industry | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 05/22/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD12 | Status: Pending Review for rule 0910-ZD12 | Request EO Meeting for rule 0910-ZD12 |
| TITLE: Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts; Draft Guidance for Industry; Availability | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 05/27/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD15 | Status: Pending Review for rule 0910-ZD15 | Request EO Meeting for rule 0910-ZD15 |
| TITLE: Requirements for Additional Traceability Records for Certain Foods: Enforcement Policy for Certain Retail Food Establishments and Restaurants | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/01/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD23 | Status: Pending Review for rule 0910-ZD23 | Request EO Meeting for rule 0910-ZD23 |
| TITLE: New Dietary Ingredient (NDI) Notifications and Related Issues; Identity and Safety Information About the NDI: Guidance for Industry | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/02/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AJ03 | Status: Pending Review for rule 0910-AJ03 | Request EO Meeting for rule 0910-AJ03 |
| TITLE: Requirements For Additional Traceability Records For Certain Foods: Compliance Date Extension | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/03/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AI91 | Status: Pending Review for rule 0910-AI91 | Request EO Meeting for rule 0910-AI91 |
| TITLE: Rulemaking to Provide by Regulation that an Ingredient Is Not Excluded From the Dietary Supplement Definition | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/05/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZC37 | Status: Pending Review for rule 0910-ZC37 | Request EO Meeting for rule 0910-ZC37 |
| TITLE: Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to their Microbiological Effects on Bacteria of Human Health Concern; Guidance for Industry | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 07/10/2025 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AJ02 | Status: Pending Review for rule 0910-AJ02 | Request EO Meeting for rule 0910-AJ02 |
| TITLE: Substances Generally Recognized as Safe | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 12/01/2025 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-HRSA | RIN: 0906-ZA23 | Status: Pending Review for rule 0906-ZA23 | Request EO Meeting for rule 0906-ZA23 |
| TITLE: Notice Regarding 340B Rebate Model Pilot Program | |||
| STAGE: Prerule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 05/27/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA11 | Status: Pending Review for rule 0925-ZA11 | Request EO Meeting for rule 0925-ZA11 |
| TITLE: Request for Information: Inviting Input on NIDA's Strategic Plan for 2027-2031 | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/15/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA12 | Status: Pending Review for rule 0925-ZA12 | Request EO Meeting for rule 0925-ZA12 |
| TITLE: Inviting Comments and Suggestions on Topic Areas for the NIDCR Strategic Plan for Fiscal Years 2027–2031 | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/15/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA13 | Status: Pending Review for rule 0925-ZA13 | Request EO Meeting for rule 0925-ZA13 |
| TITLE: Request for Information: Draft NIH Biosafety Policy for Research Involving Biohazards | |||
| STAGE: Prerule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/17/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-OCR | RIN: 0945-AA00 | Status: Pending Review for rule 0945-AA00 | Request EO Meeting for rule 0945-AA00 |
| TITLE: HIPAA Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 04/02/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-OCR | RIN: 0945-AA29 | Status: Pending Review for rule 0945-AA29 | Request EO Meeting for rule 0945-AA29 |
| TITLE: Rescinding Portions of Department of Health and Human Services Title VI Regulations to Conform More Closely with the Statutory Text and to Implement Executive Order 14281 | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 04/24/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-OCR | RIN: 0945-AA31 | Status: Pending Review for rule 0945-AA31 | Request EO Meeting for rule 0945-AA31 |
| TITLE: Rescinding Guidelines for Eliminating Discrimination and Denial of Services on the Basis of Race, Color, National Origin, Sex, and Handicap in Vocational Education Programs | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/04/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-SAMHSA | RIN: 0930-AA40 | Status: Pending Review for rule 0930-AA40 | Request EO Meeting for rule 0930-AA40 |
| TITLE: Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (UrMG) | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/11/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-SAMHSA | RIN: 0930-AA41 | Status: Pending Review for rule 0930-AA41 | Request EO Meeting for rule 0930-AA41 |
| TITLE: Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid (OFMG) | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/11/2026 | LEGAL DEADLINE: None | ||